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Abstract
Introduction and objective: Ceramidase metabolizes ceramide and generates sphingoid and fatty acid. Alkaline ceramidase has been involved in reduction of the 
ceramide level in atopic dermatitis or in aged dry skin. We hypothesized that the ceramide content can be increased by inhibition of the ceramidase activity. In this 
study, we aimed to examine the effect of alkaline ceramidase inhibitor on the amount of the ceramide in mice skin and in three-dimensional cultured epidermis model.
Material and methods: 4-Nitrobenzo-2-oxa-1,3-diazole-labeled ceramide was used as a substrate and was incubated with skin homogenate at 37˚C for 1 or 10 
h. Fluorescent-labeled fatty acid, enzymatic reaction product was detected by fluorescence high performance liquid chromatography to determine the alkaline 
ceramidase activity. The ceramide content was quantitatively analyzed by high performance thin layer chromatography.
Results: 50% Inhibitory concentration of sphingosine for alkaline ceramidase in mice skin and three-dimensional cultured epidermis model was >70-fold lower than 
the corresponding oleoylethanolamide. Ceramide [AS] and ceramide [AP] contents of sphingosine-applied group of mice stratum corneum were significantly higher 
than in the normal group. Compared with the normal group, ceramide [NDS] in three-dimensional cultured epidermis model was also significantly increased in 
sphingosine-applied group.
Conclusion: This study demonstrated that sphingosine inhibited alkaline ceramidase in mice skin and three-dimensional cultured epidermis model and ceramide 
contents was increased by application of sphingosine. These results suggest that sphingosine was beneficial compound to increase skin ceramide, though sphingosine 
may also be affected by another pathway.
Introduction
Ceramide (CER) in the stratum corneum (SC) has an important 
role in water retention as well as skin barrier function. Ceramidase 
(CDase) hydrolyzes the N-acyl linkage of CER and converts CER 
to sphingoid and fatty acid (FA). Houben and Lin reported that the 
human epidermis had acidic CDase (aCDase) and alkaline CDase 
(alkCDase) activities [1,2]. It was also demonstrated that alkCDase 
1 mRNA expression level in human epidermis was higher than 
other tissues; total alkCDase and aCDase were activated, and mRNA 
expression of alkCDase 1 and aCDase was increased by differentiation 
of keratinocyte [3].
Skin barrier function is altered by skin conditions such as aging and 
atopic dermatitis (AD). Imokawa and Ghadially revealed a decrease in 
the CER content in SC in aged human and hairless mice [4,5]. Jin et 
al. demonstrated that the alkCDase activity (pH 9.0) was elevated in 
aged human SC compared with young [6]. AD patients showed high 
transepidermal water loss (TEWL) and low total CER content in SC 
[4]. Sphingomyelin deacylase and glucosylceramide deacylase were 
closely related to AD [7]. However, Okino found that alkCDase was 
secreted from Pseudomonas aeruginosa in skin of AD patients [8,9] 
and considered that it subsequently decreased the CER content [10]. 
But little has been reported on regulation of the CER content in SC by 
inhibition of the CDase.
We then hypothesized that CDase inhibitor may increase the 
CER content in SC. Yada and Mao reported that sphingosine (SPH) 
inhibited mouse alkaline ceramidase (maCER1) and guinea pig 
epidermal alkCDase activity [11,12]. In this study, we used hairless 
mice and three-dimensional cultured epidermis model, and reported 
the effects of SPH on the alkCDase activity and the CER content.
Material and methods
Animals and three-dimensional cultured epidermis model
Male HOS:HR-1 mice, 4 and 7 week sold, were purchased from 
Japan SLC, Inc. (Hamamatsu, Shizuoka, Japan) and were kept under 
a 12-h light and 12-h dark cycle in a conventional animal room 
maintained at 22 ± 2°C; 55% ± 5% and free access to food and water. All 
procedures were approved by the Ethics Committee of Josai University 
(Sakado, Saitama, Japan). Six-day cultured LabCyte EPI-MODEL was 
obtained from Japan Tissue Engineering Co., Ltd. (Gamagori, Aichi, 
Japan).
Materials
Fluorescent-labeled 4-nitrobenzo-2-oxa-1,3-diazole (NBD) group 
FAs (C6-NBD-FA and C12-NBD-FA) were purchased from Molecular 
Probes (Eugene, OR, USA) and Invitrogen (Waltham, MA, USA). C12-
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NBD-CER was purchased from Cayman Chemical Company (Ann 
Arbor, MI, USA). Oleoylethanolamide (OEA) was obtained from 
Enzo Biochem, Inc. (New York, NY, USA). D-Erythro-sphingosine 
was obtained from Wako Pure Chemical Industries (Osaka, Japan). 
CER standard for quantitative determination was obtained from 
Matreya, LLC (Pleasant Gap, PA, USA), Evonik Industries (Essen, 
North Rhine-Westphalia, Germany), and Takasago International 
Corporation (Tokyo, Japan). Dipalmitoylphosphatidylcholine (DPPC) 
and dipalmitoylphosphatidylglycerol (DPPG) were kindly donated by 
Nippon Fine Chemical (Osaka, Japan). Other reagents were obtained 
from Wako Pure Chemical Industries, Daiichi Sankyo Co., Ltd. (Tokyo, 
Japan), Tokyo Chemical Industry Co., Ltd. (Tokyo, Japan), Alfa Aesar 
(Heysham, Lancashire, UK) and Sigma-Aldrich Co., LLC. (St. Louis, 
MO, USA).
Preparation of homogenate
Mice were killed by cervical dislocation and dorsal skin was obtained. 
Subcutaneous tissue was removed by scissors. After weighing, the skin 
was minced using scissors for 3 min on ice and was homogenized in 
0.25 M sucrose, supplemented with 1% Triton X-100 using Polytron 
PT 1200 E homogenizer (Kinematica AG, Luzernerstrasse, Lucern, 
Switzerland) at 25,000 rpm for 1 min on ice. The homogenate was 
centrifuged at 500×g at 4°C for 1 min and the supernatant was stored 
at −30°C until use. Three-dimensional cultured epidermal models were 
collected from transwell by spatula and homogenized, as described 
above. Protein concentration was determined by a modified Lowry 
method.
Measurement of the alkCDase and aCDaseactivity
The CDase activity was measured by the method of Houben et 
al., with some modifications [1]. NBD-C12-CER was used as substrate 
of CDase. An appropriate amount of NBD-C12-CER, with final 
concentration of 250 μM, was dissolved in methanol and allowed to 
dry under nitrogen gas. The substrate was redissolved by sonication 
(50°C, 10 min) in 12.5 μl of detergent mixture containing 40 mg/ml 
Triton X-100, 16 mg/ml Tween 80, and 25 μl of 250 mM Tris-HCl 
buffer (for alkCDase, pH 8.5) or acetate buffer (for aCDase, pH 4.2). 
Mice skin or three-dimensional cultured epidermis model homogenate 
was preincubated at 37°C for 2 min. Enzymatic reactions were initiated 
by the addition of 12.5 μl of 60 ng protein/ml homogenate, and the final 
concentration was 15 ng protein/ml to the substrate solution at 37°C. 
Incubation time was 1 h for mice skin or 10 h for three-dimensional 
cultured epidermis model. The reaction was stopped by addition of 300 
μl of chloroform/methanol (2:1) that contained 0.26 μM NBD-C6-FA 
as internal standard for HPLC analysis. The reaction mixture was dried 
under nitrogen gas and dissolved in 100 μl of methanol. HPLC system 
(SHIMADZU Prominence HPLC system, SHIMADZU Corp., Kyoto, 
Kyoto, Japan), equipped with a reversed phase L-Column 2 ODS (5 
μm, 2.1×150 mm; Chemicals Evaluation and Research Institute, Tokyo, 
Japan), and a fluorescence detector (RF-10AXL, SHIMADZU) set to 
excitation and emission wavelengths of 460 and 534 nm, respectively, 
were used to determine NBD-C12-FA in the enzymatic reaction sample. 
Column was maintained at 30°C. The mobile phases were 0.1% formic 
acid in acetonitrile (A) and 0.1% formic acid in water (B). A binary 
mobile phase at a flow rate of 0.4 ml/min was used under liner gradient 
conditions as follows: 0 min, 30% A; 0–5 min, 30%–100% A; 5–14.5 
min, 100% A; 14.5–14.51 min, 30% A; 14.51–30 min, 30% A. Standard 
curve of peak height ratio (NBD-C12-FA vs. internal standard) was 
used to determine NBD-C12-FA that was formed during the enzymatic 
reaction. To correct the CDase activity values, the NBD-C12-FA content 
in an incubated reaction mixture without protein was subtracted from 
that in a reaction mixture with protein. To assess inhibitory effect, 
SPH dissolved in methanol was added to the substrate and dried. The 
inhibitory activity was measured as described above. OEA, which has 
the inhibitory activity for alkCDase and aCDase [1], was used as a 
positive control of CDase inhibitor.
Application of SPH and extract of SC lipids in mice
SPH and OEA were dissolved in propyleneglycol/ethanol (7:3; 
concentration, 40 mM) [13]. Samples of 50 μl were applied twice a 
day for three days to the dorsal skin (area, 5–6 cm2) of mice. Control 
group was exposed to propyleneglycol/ethanol (7:3). SC sheet was 
collected by stripping the dorsal skin area with applied sample with 
cyanoacrylate resin and was stored frozen at −80°C until use. Lipids 
were extracted by the method of Imokawa et al. [4]. SC sheets were 
immersed in hexane/ethanol (95:5) and sonicated for 20 min. Solutions 
of extracted lipids were filtered (MILLEX-GV Syringe Driven Filter 
Unit, Merck Millipore, MA, USA) and transferred to test tubes. 
Organic solvent was dried under nitrogen gas stream at 50°C. Lipid in 
test tube was dissolved in chloroform/methanol (2:1) and sonicated at 
37°C for 5 min. Extract was transferred to a 1.5 ml tube and dried. SC 
lipid samples were stored frozen at −80°C until use.
Application of SPH and extraction of epidermal lipids for 
three-dimensional cultured epidermis model
Liposome constructed SPH/DPPC/DPPG (molar ratio 4:4:1) 
was prepared by the thin layer method previously described [14]. 
SPH concentration in a liposome was 10 mM. Three-dimensional 
cultured epidermis model was cultured at 37°C under 5% CO2. A 50 
μl solution of liposome containing SPH was applied to the SC side 
of three-dimensional cultured epidermis model for 6 days and was 
changed every 2 days. Medium was changed every day for 6 days and 
was supplied with 25 μg/ml ascorbic acid on the seventh day. After 
24 h, three-dimensional cultured epidermis model was collected 
from transwell by scalpel. Control group was applied with SPH-free 
liposome (DPPC/DPPG, 4:1). Three-dimensional cultured epidermal 
samples were immersed in chloroform/methanol (2:1) and sonicated by 
SONIFIRE 250 (Branson, Danbury, CT, USA) on ice. Lipid collection 
was conducted as described above.
Quantification of the CER
The CER was quantitated by the method of Imokawa et al. [4]. 
Extracted lipids were redissolved in chloroform/methanol (2:1) and 10 
μl of extract was spotted by capillary on the high-performance thin-
layer chromatography (HPTLC) Silica gel 60, measuring 20×10 cm 
(Merck Millipore). The CER was isolated by chloroform/methanol/
acetic acid (190:9:1 to 9 cm) and was developed twice. The HPTLC 
plate was sprayed with coloring reagent (10% cupric sulfate, 8% 
phosphoric acid) and heated at 180°C for 10 min by TLC Plate Heater 
III (CAMAG, Muttenz, Switzerland). HPTLC plate was imaged by 
LAS1000-plus (Fujifilm Corporation, Tokyo, Japan) and the CER was 
quantitated from band density by Multi Gauge Version 3.0 (Fujifilm 
Corporation).
Data analysis
Data were expressed as the mean ± S.D. (n=4) and compared by 
Turkey’s test, Dunnett’s test, or Student’s t-test using SAS version 9.2 
(SAS Institute ltd., Cary, NC, USA).
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Results
The CDase activity in mice skin
Activity of alkCDase in the presence of 10 mM SPH on mice skin 
homogenate was measured. Compared with the normal group, the 
alkCDase activity was significantly reduced by 46% in OEA (positive 
control) group (p<0.05) and 88% in SPH group (p<0.001). The 
alkCDase activity in the SPH group was significantly decreased by 78% 
(p<0.05) relative to the OEA group (Figure 1A). Similarly, the aCDase 
activity in the SPH group had a tendency to be lower than that in 
normal group, in spite of no significant (Figure 1B). Subsequently, the 
inhibitory activity of SPH on the alkCDase was determined. SPH and 
OEA dose-dependently inhibited the alkCDase activity (Figure 2). The 
IC50 value of SPH was significantly lower than that of OEA (p<0.001) 
(Table 1).
The CER content in mice SC
The CER content in mice SC was measured after application of 40 
mM SPH or OEA. CER [NS] and CER [NP] contents were not changed 
by the application of OEA or SPH (Figure 3A and 3B). In contrast, 
CER [AS] in the SPH group was significantly increased relatively to 
the normal group (p<0.05) (Figure 3C). CER [AP] content was also 
significantly increased by application of SPH when compared with the 
normal group (p<0.001) (Figure 3D).
The alkCDase activity in three-dimensional cultured 
epidermis model
Activity of alkCDase in the presence of 10 mM SPH on the three-
dimensional cultured epidermis model homogenate was measured. 
Compared with the normal group, the alkCDase activity was 
significantly decreased by 56% in OEA group and 83% in SPH group 
(p<0.001). The alkCDase activity in the SPH group was significantly 
reduced by 62% (p<0.01) relatively to the OEA group (Figure 4). SPH 
and OEA inhibited alkCDase in a dose-dependent manner (Figure 
5). In agreement with the animal experiment, the IC50 value of SPH 
for alkCDase was significantly reduced compared with that of OEA 
(p<0.01) (Table 2).
The CER content in three-dimensional cultured epidermis 
model
The CER content was measured after application of liposome 
containing 10 mM SPH. SPH did not change the amounts of CER [NS], 
CER [NP], CER [AS], and CER [AP] (Figure 6A-6D). However, CER 
[NDS] was significantly increased in the SPH group in comparison 
with the normal group (p<0.001) (Figure 6E).
Discussion
First, the inhibitory activity of SPH for alkCDase was assessed by 
comparison with OEA (positive control). The IC50 values of SPH were 
lower than OEA (Tables 1 and 2). Mao et al. reported that the IC50 
Figure 1: Effect of SPH on the CDase activity in hairless mice skin homogenate (n=4)
OEA was used as positive control. OEA and SPH concentrations were 10 mM. The 
alkCDase activity at pH 8.5 (A) and the aCDase activity at pH 4.2 (B). Values are expressed 
as the mean ± S.D. *p<0.05, ***p<0.001, as determined by Turkey’s test.
Figure 2: The alkCDase activity in hairless mice skin homogenate in the presence of 
alkCDase inhibitors at various concentrations (n=4)
OEA was used as positive control. The alkCDase activity of control was measured in an 
alkCDase inhibitor-free condition. SPH (0.03–0.18 mM) (A) and OEA (4–12 mM) (B). 
Values are expressed as the mean ± S.D.
Figure 3: The CER content in SC of hairless mice after topical application of OEA or SPH 
(n=4)
OEA and SPH concentrations were 40 mM. Control group was applied with propyleneglycol/
ethanol (7:3). Content of CER [NS] (A), CER [NP] (B), CER [AS] (C), and CER [AP] (D). 
Values are expressed as the mean ± S.D. *p<0.05, **p<0.01, ***p<0.001, determined by 
Turkey’s test.
Inhibitor IC50 value (mM)
OEA 11.1 ± 1.59
SPH 0.09 ± 0.01 ***
Values are expressed as the mean ± S.D. (n=4). ***p<0.001, determined by Student’s t-test.
Table 1. IC50 values of alkCDase inhibitors on the hairless mice skin homogenate.
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value of SPH for maCER1 (pH 8.0) was −0.08 mM [12]. The mice skin 
IC50 values of SPH reported in this paper were similar to the previous 
study. In addition, the IC50 values of SPH and OEA were similar 
between mice skin and three-dimensional cultured epidermis model 
(Tables 1 and 2). These data indicated that SPH is a stronger inhibitor 
of alkCDase than OEA. Subsequently, mice SC CER after application of 
SPH or OEA was determined. SPH concentration of 40 mM was higher 
than the intracellular level. However, we considered that the SPH 
amount in the viable epidermis was low because SPH penetration was 
prevented by the SC barrier. CER in the SC was shown to be composed 
of 4 types of sphingoids; namely, SPH [S], dihydrosphingosine [DS], 
phytosphingosine [P], and 6-hydroxy sphingosine [H]; and 3 types of 
FAs; namely, non-hydroxy FA [N], α-hydroxy FA [A], and esterified 
ω-hydroxy FA [EO]. CER [AS] and CER [AP] were increased by 
application of SPH (Figure 3C and 3D). Mao et al. demonstrated 
that maCER1 (pH 8.0) had specificity for CER containing D-erythro-
sphingosine, but CER had D-ribo-phytosphingosine and D-erythro-
dihydrosphingosine was not hydrolyzed [12]. Thus, it is likely that 
degradation of CER [AS], which contains D-erythro-sphingosine, 
was suppressed by inhibition of alkCDase. However, CER [NS] that 
also contained D-erythro-sphingosine, was not increased (Figure 
3A); whereas, CER [AP] that contained D-ribo-phytosphingosine was 
increased (Figure 3D). Therefore, we considered that a mechanism 
other than alkCDase inhibition is also related to the increase of the CER. 
Further, the CER content in three-dimensional cultured epidermis 
model after application of SPH was also quantitated. We prepared 
a liposome containing SPH for application to three-dimensional 
cultured epidermis model because SPH was a lipophilic compound. 
The CER content of the control group with SPH-free liposome (DPPC/
DPPG, 4:1) was unchanged (Figure 6). Unlike the results on mice SC, 
CER [AS] and CER [AP] were unchanged; however, CER [NDS] was 
increased (Figure 6C-6E). Density of CER [NDS] in HPTLC analysis 
Figure 4: Effect of SPH on the alkCDase activity in three-dimensional cultured epidermis 
model homogenate (n=4)
OEA was used as a positive control. OEA and SPH concentrations were 10 mM. Values are 
expressed as the mean ± S.D. **p<0.01, ***p<0.001, determined by Turkey’s test.
Figure 5: The alkCDase activity in three-dimensional cultured epidermis model 
homogenate in the presence of alkCDase inhibitors at various concentrations (n=4)
OEA was used as a positive control. The alkCDase activity of control was measured in 
an alkCDase inhibitor-free condition. SPH (0.03-0.18 mM) (A) and OEA (2-10 mM) (B). 
Values are expressed as the mean ± S.D. 
Figure 6: The CER content in three-dimensional cultured epidermis model after application 
of SPH liposome (n=4)
Liposome contained 10 mM SPH. Control group was applied with SPH-free liposome 
(DPPC/DPPG, 4:1). Content of CER [NS] (A), CER [NP] (B), CER [AS] (C), CER [AP]
(D), and CER [NDS] (E). Values are expressed as the mean ± S.D. ***p<0.001, determined 
by Turkey’s test.
Inhibitor IC50 value (mM)
OEA 7.77 ± 1.21
SPH 0.11 ± 0.03 **
Values are expressed as the mean ± S.D. (n=4). **p<0.01, determined by Student’s t-test.
Table 2. IC50 values of alkCDase inhibitors in the three-dimensional cultured epidermis 
model homogenate.
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from mice SC was unchanged (data not shown). CER [NDS] density 
was increased, in spite of no significant, by application of liposome 
containing 1 mM SPH (data not shown). It was reported that CER 
[NP], CER [NH], and CER [AH] were popular classes (22.1, 14.5, 
and 10.8% respectively) among the total CER content of human SC 
and that CER [EOS] accounted for 6.5% [15]. Simotoyodome et al. 
also showed that CER [NP] and CER [NH] existed in abundance in 
human SC CER [16]. However, Liou et al. reported that CER [EOS] 
was dominant (approximately 75%) in nude mice skin CER [17]. These 
reports indicated that the generation profile of individual SC CER 
classes maybe different between human and mice. Hence, we thought 
that different CER classes were increased between mice SC and three-
dimensional cultured epidermis model by the same compound. Duan 
et al. reported that the mRNAs of ceramide synthase (CerS) 2, CerS3, 
and CerS4 in normal human foreskin keratinocytes were upregulated 
by dihydrosphingosine, sphingosine, and 4,8-sphingadienine purified 
from maize glucosylceramide [18]. Shirakura et al. reported an 
increased mRNA expression of the enzyme related to CER production 
and that CER [EOS], CER [NS], and CER [NP] were increased by 
application of 4,8-sphingadienine and 4-hydroxy-8-sphinganine 
isolated from konjac glucosylceramide to three-dimensional cultured 
epidermis model [19]. Sigruener et al. also reported that sphingoids 
increased the mRNA level of sphingolipid metabolizes enzymes and 
the CER contents in human keratinocyte [20]. Thus, it is probable that 
de novo synthesis of CER was stimulated by SPH in our experiment. 
Sphingosine-1-phosphate (S1P) is generated from SPH by sphingosine 
kinase (SPHK) and induces keratinocyte differentiation [21]. Hong et 
al. demonstrated that specific differentiation-associated maker proteins 
in intact mice epidermis and HaCaT cells were increased by application 
of SPHK activator [22]. Thus, it is likely that SPH applied to mice or 
three-dimensional cultured epidermis model was metabolized to S1P 
and differentiation of keratinocyte was promoted; consequently, the 
CER was increased. It was known that a salvage pathway reconverted 
SPH to CER [23], but it was still unclear whether it contributed to skin 
barrier.
Conclusion
We revealed that SPH was a stronger inhibitor than OEA to 
increase the CER contents, indicating that SPH suppresses degradation 
of CER in SC by inhibition of alkCDase. However, SPH may also be 
affected by another pathway, like de novo synthesis. Thus, SPH may be 
a beneficial compound to increase skin CER.
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